What Is IMMUNOSCORE®?
A powerful tool that adds a new dimension of insight into cancer
Immunoscore® provides a robust, precise, quantitative, and consensus assessment of lymphocytic infiltration in human tumors and has been shown to predict patient outcome: response to therapies in several indications.
Publication
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
View
IMMUNOSCORE® Accurately measures patient immune response at the tumor site
IMMUNOSCORE® is a sophisticated tissue-based assay providing a score defined with the precise quantification and identification of T lymphocytes infiltrating the tumor in specific regions. This personalized medicine tool has been shown to predict patient outcomes in several indications.
Developing the IMMUNOSCORE®
“The data made it quite clear - the higher the number of immune cells, the better the life expectancy, a correlation that we named the IMMUNOSCORE®.”
Jérôme Galon, PhD.
Inventor of IMMUNOSCORE®
IMMUNOSCORE® for Healthcare Professionals
Based on 15+ years of research on thousands of patients, IMMUNOSCORE® can guide treatment decision-making by giving healthcare professionals a clear and actionable measurement of how an individual patient’s immune system is responding to their cancer.
IMMUNOSCORE® is available for a growing number of indications.
IMMUNOSCORE® and related services for Pharma
Leveraging a wide array of the latest imaging and genomics technologies, IMMUNOSCORE® and related services can reveal critical tumor immune response insights to guide therapeutics and diagnostics development. Build a detailed understanding of a product’s mechanism of action, each patient’s individual tumor immune response, and more to make strategic decisions about clinical development based on the best data available.
